Squarepoint’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-79,700
Closed -$64.2K – 5169
2024
Q4
$64.2K Buy
+79,700
New +$73K ﹤0.01% 4801

Other funds holding OCGN

Squarepoint's OCGN Position: Q2 2026 in Review

Squarepoint reduced its Ocugen (OCGN) stake by 69% in Q2 2026, selling an estimated $452K and leaving 136,711 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #4039.

Squarepoint first reported a position in OCGN in Q1 2020 and has held it in 16 quarters since. The position peaked at $954K in Q2 2021. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Squarepoint held 136,711 shares of Ocugen worth $209K as of Q2 2026.
  • Squarepoint sold 297,298 Ocugen shares in Q2 2026, an estimated $452K.
  • Ocugen made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4039 holding.
  • Squarepoint first reported a position in Ocugen in Q1 2020 and has held it in 16 quarters since.
  • Squarepoint's Ocugen position peaked at $954K in Q2 2021.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.